SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-20-002732
Filing Date
2020-11-06
Accepted
2020-11-06 16:50:54
Documents
61
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q embi_10q.htm 10-Q 580443
2 EX-31.1 embi_ex311.htm EX-31.1 9008
3 EX-31.2 embi_ex312.htm EX-31.2 9188
4 EX-32.1 embi_ex321.htm EX-32.1 4010
5 EX-32.2 embi_ex322.htm EX-32.2 3971
  Complete submission text file 0001640334-20-002732.txt   5103864

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT embi-20200930.xml EX-101.INS 942116
7 XBRL TAXONOMY EXTENSION SCHEMA embi-20200930.xsd EX-101.SCH 78095
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE embi-20200930_cal.xml EX-101.CAL 26849
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE embi-20200930_def.xml EX-101.DEF 254229
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE embi-20200930_lab.xml EX-101.LAB 780114
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE embi-20200930_pre.xml EX-101.PRE 364357
Mailing Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121 (949) 480-9051
Emerald Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55136 | Film No.: 201295100
SIC: 2834 Pharmaceutical Preparations